IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces An Investigation of Claims against DaVita HealthCare Partners Inc. ...
February 12 2016 - 01:55PM
Business Wire
Khang & Khang LLP announces that it is investigating claims
of potential misrepresentations by DaVita HealthCare Partners Inc.
(“DaVita” or the “Company”) (NYSE: DVA). The investigation focuses
on whether the Company and its officers violated securities laws by
issuing misleading information to investors.
If you purchased shares of DaVita during the Class Period,
please contact Joon M. Khang, Esquire, of Khang & Khang, 18101
Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949)
419-3834, or by e-mail at joon@khanglaw.com.
There has been no class certification in this case. Until
certification occurs, you are not represented by an attorney. You
may choose to take no action and remain a passive class member.
On February 11, 2016, the Company announced that the U.S.
Attorney's Office for the Northern District of Texas had sent it a
Civil Investigative Demand (CID) concerning a False Claims Act
investigation. According to the allegations, DaVita submitted false
claims to the government for prescription drug reimbursement. When
the truth was revealed, shares dropped causing investors harm.
If you wish to learn more about this lawsuit, or if
you have any questions concerning this notice or your rights,
please contact Joon M. Khang, a prominent litigator for almost two
decades, by telephone: (949) 419-3834, or by e-mail at
joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160212005755/en/
Khang & Khang LLPJoon M. Khang, Esq.Telephone:
949-419-3834Facsimile: 949-225-4474joon@khanglaw.com
DaVita (NYSE:DVA)
Historical Stock Chart
From Feb 2024 to Mar 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Mar 2023 to Mar 2024